Zobrazeno 1 - 10
of 26
pro vyhledávání: '"59"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Breast cancer and its treatment imposes a significant effect in the quality of life (QOL) of women. Being a developing country with contrasting social and cultural norms to the West, Sri Lankan women may have a different experience on QOL
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-6 (2020)
Radiation oncology (London, England), vol 15, iss 1
Radiation Oncology (London, England)
Radiation oncology (London, England), vol 15, iss 1
Radiation Oncology (London, England)
Background Whole-brain radiotherapy (WBRT) remains an important treatment for over 200,000 cancer patients in the United States annually. Hippocampal-avoidant WBRT (HA-WBRT) reduces neurocognitive toxicity compared to standard WBRT, but HA-WBRT conto
Autor:
Stewart J. Becker, Kai Sun, Shifeng Chen, Young Kwok, Emily Morse, Narottam Lamichhane, E.S. Kowalski, William F. Regine, Rahul Khairnar, Hua-Ren Cherng, Mark V. Mishra, Yannick Poirier, Gregory S. Alexander, Lars J. Berg, Jason K. Molitoris, Jill Remick
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-10 (2020)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Purpose Stereotactic radiation therapy (SRT) and immune checkpoint inhibitors (ICI) may act synergistically to improve treatment outcomes but may also increase the risk of symptomatic radiation necrosis (RN). The objective of this study was to compar
Autor:
Yang-Hong Dai, Meei-Shyuan Lee, Cheng-Hsiang Lo, Jen-Fu Yang, Hsing-Lung Chao, Po-Chien Shen, Chun-Shu Lin, Wen-Yen Huang
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background This study aimed to compare the clinical outcomes of stereotactic ablative radiotherapy (SABR) and conventionally fractionated radiotherapy (CFRT) in hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI). Methods HCC pati
Autor:
Yi-Hung Kuo, Wen-Shih Huang, Yun-Ching Huang, Chih-Jung Chen, Chih-Chien Chin, Chia-Hsuan Lai, Cheng-Yi Huang
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Cancer
BMC Cancer
Background Current advancements in neoadjuvant therapy and total mesorectal excision have engendered increased local control. However, the survival benefit of preoperative radiotherapy (RT; 5 × 5 Gy) in rectal cancer patients remains inadequate, pri
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Cancer
BMC Cancer
Background Purpose of this study was to analyze whether preoperative maximum standardized uptake value (SUVmax) and carbohydrate antigen 19–9 (CA19–9) levels might provide prognostic information in Chinese patients with pancreatic duct adenocarci
Autor:
Jianzhong Shou, Lin Li, Zhendong Xiao, Changling Li, Kaopeng Guan, Shan Zheng, Jun Tian, Zejun Xiao, Xingang Bi, Chuanzhen Cao, Jianhui Ma, Dong Wang, Jing Liang, Huijuan Zhang
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer
BMC Cancer
Background Previous related studies have mainly focused on renal cell carcinoma (RCC) with venous tumor thrombus, specifically inferior vena cava tumor thrombus with renal vein tumor thrombus (RVTT). However, only a few studies have focused on postop
Autor:
Naoyuki Sone, Takashi Niwa, Hiroshige Yoshioka, Tadashi Ishida, Takashi Ogura, Toshihide Yokoyama, Satoshi Ikeda, Akimasa Sekine, Akihiro Nishiyama, Satoshi Ikeo, Mitsunori Morita
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
BMC Cancer
BMC Cancer
Background There have been few data on the chemotherapy in elderly advanced non-small cell lung cancer (NSCLC) patients with poor performance status (PS), and usefulness of chemotherapy for such patients remains unclear. The objective of this study w
Publikováno v:
Clinical Sarcoma Research, Vol 7, Iss 1, Pp 1-15 (2017)
Clinical Sarcoma Research
Clinical Sarcoma Research
Background Since treatment patterns in metastatic soft tissue sarcoma (mSTS) have not been studied subsequent to US approval of pazopanib in 2012, this study sought to examine mSTS treatment patterns by line of therapy, including regimen and duration
Autor:
Maha S. Jawad, Frederick Mantel, Arjun Sahgal, Brian Winey, John C. Flickinger, Inga S. Grills, Peter C. Gerszten, John Cho, Johannes Roesch, John H. Shin, Matthias Guckenberger, Daniel K. Fahim, Ronald Kersh, Daniel Letourneau
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-8 (2017)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Object Stereotactic body radiotherapy (SBRT) for vertebral metastases has emerged as a promising technique, offering high rates of symptom relief and local control combined with low risk of toxicity. Nonetheless, local failure or vertebral instabilit